About Vernal
Vernal is a company based in New York (United States) founded in 2010 was acquired by Orioninc in March 2017. Vernal operates in a competitive market with competitors including Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and IMIDomics, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Vernal
Detailed funding history for Vernal
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Vernal
Vernal has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Orioninc and Potomac Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Potomac Equity Partners is engaged in private equity investments.
|
Locked | Locked | Locked | |
|
Provider of AI, data analytics, application development and IT security services
|
Locked | Locked | Locked |
Investor details for Vernal
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vernal
Investment portfolio details for Vernal
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vernal
Detailed financials for Vernal
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vernal Comparisons
Peer comparison for Vernal
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vernal
Vernal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and IMIDomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic molecules are discovered through AI and quantum physics integration.
|
|
| Locked | Locked | Locked |
Provider of bio informatics platform to develops biologics and therapeutics
|
|
| Locked | Locked | Locked |
Combinatorial chemistry services for peptide-based drug discovery are provided.
|
|
| Locked | Locked | Locked |
Systems biology and pharmacology modeling services to aid drug discovery and development
|
|
| Locked | Locked | Locked |
Precision medicines for immune-mediated inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Software solutions for computational chemistry are developed and provided.
|
Detailed competitors of Vernal
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vernal
Complete news archive for Vernal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vernal
Vernal was founded in 2010.
Vernal is headquartered in New York, United States. It is registered at New York, New York, United States.
Vernalis was founded in 2010 and is headquartered in New York, United States. Operations focus on the biotechnology sector, where a specialized platform for fragment and structure-based drug discovery is utilized. Services encompass early-stage research tools and methodologies to support pharmaceutical development. The company operates primarily in the United States, aiding clients in identifying potential drug candidates through advanced structural analysis techniques.
Vernal has 2 investors. Key investors include Orioninc, and Potomac Equity Partners.